13D Filing: QVT Financial and Arbutus Biopharma Corp (ABUS)

Page 4 of 9 – SEC Filing


CUSIP No. 03879J100

  1.

Names of
Reporting Persons.

QVT Fund V LP

  2.

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☒

  3.

SEC Use Only

  4.

Source of Funds (See Instructions)

WC

  5.

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)

  6.

Citizenship or Place of
Organization

Cayman Islands

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7. 

Sole Voting Power

0

  8.

Shared Voting Power

0

  9.

Sole Dispositive Power

0

10.

Shared Dispositive Power

16,013,540

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

16,013,540

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)

13.

Percent of Class Represented by Amount
in Row (11)

29.1%

14.

Type of Reporting Person (See
Instructions)

PN

4

Follow Arbutus Biopharma Corp (NASDAQ:ABUS)